A 30-Year Perspective {#s0010}
=====================

Infectious diseases, whether caused by bacteria, viruses, or parasites, are complex, dynamic, and constantly evolving. Some emerge or reemerge in human populations as they cross the species barrier from animals to humans, and once they have infected humans they may be asymptomatic or cause disease. If they cause disease, they may maintain their virulence or decrease in virulence with further passage through human populations. While some of these infectious agents transmit easily from human to human causing epidemics or pandemics, others may not be transmissible, but continue to sporadically infect humans as zoonotic infections. Still others, like HIV infection, may eventually become endemic infectious diseases in humans.

Examples of emerging infectious diseases are numerous and clearly demonstrate their complexity, dynamism, and evolution. In the Democratic Republic of Congo, the cessation of smallpox vaccination in 1980, after smallpox had been eradicated, may have contributed to a change in the transmission patterns of human monkeypox. Smallpox vaccine also protects against other orthopox virus infections of humans, including monkeypox. During the 1970s and 1980s, when human monkeypox was the subject of extensive study and the majority of humans were still vaccinated against smallpox, it was shown that person-to-person transmission beyond three generations was rare. In 1996--97, an outbreak of human monkeypox occurred with transmission through at least nine generations and probably more, and large chains of human to human transmission of monkeypox have continued intermittently since then. Poverty and civil unrest appear to be factors that contribute to the increase in human monkeypox infections, and these infections are now better able to sustain transmission because succeeding generations are no longer vaccinated.

Numerous other infectious diseases have likewise shown the potential to emerge, reemerge and transmit from human to human ([Table 1](#t0005){ref-type="table"}). In the early to mid-1970s, for example, classic dengue fever had just begun to reappear in Latin America after it had been almost eliminated as a result of mosquito control efforts in the 1950s and 1960s. During the early 1970s, dengue continued to reemerge, with unprecedented numbers of its hemorrhagic form. Thirty years later, in 2001, Latin America reported over 609 000 cases of dengue, of which 15 000 were of the hemorrhagic form. These figures represent more than double the cases reported for the same region in 1995. Table 1Principal newly identified infectious organisms associated with diseasesYearNewly identified organismDisease (year and place of first recognized or documented case)*Diseases primarily transmitted by food and drinking water*1973RotavirusInfantile diarrhea1974Parvovirus B19Fifth disease1976*Cryptosporidium parvum*Acute enterocolitis1977*Campylobacter jejuni*Campylobacter enteritis1982*Escherichia coli* 0157:H7Hemorrhagic colitis with hemolytic uremic syndrome1983*Helicobacter pylori*Gastric ulcers1986*Cyclospora cayatanensis*Persistent diarrhea1989Hepatitis E virusEnterically transmitted non-A and non-B hepatitis (1979, India)1992*Vibrio cholerae* 0139New strain of epidemic cholera (1992, India)*Unclear modes of transmission, thought to be primarily transmitted by drinking water*1985*Enterocytozoon bieneusi*Diarrhea1991*Encephalitozoon hellem*Systemic disease with conjunctivitis, in AIDS patients1993*Encephalitozoon cunicali*Parasitic disseminated disease, seizures (1959, Japan)1993*Septata intestinalis*Persistent diarrhea in AIDS patients*Diseases primarily transmitted by close contact with infectious individuals, excluding sexually transmitted diseases, nosocomialinfections, and viral hemorrhagic fevers*1980HTLV-1T-cell lymphoma-leukemia1982HTLV IIHairy cell leukemia1988HHV-6Rosela subitum1993Influenza A/Beijing/32 virusInfluenza1995HHV-8Associated with Kaposi sarcoma in AIDS patients1995Influenza A/Wuhan/359/95 virusInfluenza2003SARS coronavirusSARS*Sexually transmitted diseases*1983HIV-1AIDS (1981)1986HIV-2Less pathogenic than HIV-1 infection*Nosocomial and related infections*1981Staphylococcus toxinToxic shock syndrome1988Hepatitis CParenterally transmitted non-A, non-B hepatitis1995Hepatitis G virusesParenterally transmitted non-A, non-B hepatitis*Human zoonoses and vector-borne diseases, including viral hemomorrhagic fevers, transmitted by close contact with animalsor animal products, excluding food-borne diseases*1977Hantaan virusHemorrhagic fever with renal syndrome (1951)1990Reston strain of Ebola virusHuman infection documented but without symptoms (1990)1991Guanarito virusVenezuelan hemorrhagic fever (1989)1992*Bartonella henselae*Cat-scratch disease (1950s)1993Sinnombre virusHantavirus pulmonary syndrome (1993)1994Sabiä virusBrazilian hemorrhagic fever (1955)1997Influenza A (H5N1)Avian influenza1998Nipah virusSevere encephalitis*Tick-borne*1982*Borrelia burgdorferi*Lyme disease (1975)1989*Ehrlichia chaffeensis*Human ehrlichiosis1991New species of *Babesia*Atypical babesiosis*Unknown animal vector*1977Ebola virusEbola hemorrhagic fever (1976, Democratic Republic of Congo and Sudan)1994Ebola virus, Ivory Coast strainEbola hemorrhagic fever*Soil-borne diseases, airborne diseases and diseases associated with recreational water with no evidence of direct person-to-persontransmission*1976*Legionella pneumophila*Legionellosis (1947)[^1]

Dengue outbreaks are also becoming more numerous and lethal. An outbreak in Brazil in 2002 caused over 500 000 cases in one of the largest outbreaks ever recorded. In 1998, over 1.2 million cases of dengue fever and dengue hemorrhagic fever were reported from 56 countries. Today, dengue is occurring in epidemics in more than 100 countries in Africa, the Americas, the Eastern Mediterranean, Southeast Asia and the Western Pacific. Dengue outbreaks in Indonesia began during the early 2000s, and have resulted in over 60 000 reported cases with more than 700 deaths in this country alone.

In 1991, cholera, which had not been reported in Latin America for over 100 years, reemerged in Peru with over 320 000 cases and nearly 3000 deaths. It rapidly spread throughout the continent to cause well over 1 million cases in a continuing and widespread epidemic. Fifteen years earlier, in 1976 in North America, *Legionella* infection was first identified in an outbreak among war veterans attending a conference in Philadelphia (USA). *Legionellosis* is now known to have occurred in outbreaks many years prior to that date. Today it occurs worldwide, posing a threat to travelers exposed to water from many different sources including poorly maintained air conditioning systems because the organisms are resistant to chlorination. In the Netherlands, in 1999, an outbreak of *Legionellosis* occurred, which was subsequently traced to exposure to mist from whirlpool baths exhibited at a flower show visited by 80 000 people. Local cooling towers are considered the likely source of a large outbreak of *Legionellosis*, involving 751 cases and two deaths, which occurred in Spain in 2001.

In 1986 a new disease in cattle, bovine spongiform encephalopathy (BSE), was first identified in the United Kingdom. In 1996, the appearance of a previously unknown variant of the invariably fatal Creutzfeldt-Jakob disease appeared in humans, and this has now been shown to be caused by the same infectious agent that causes BSE in cattle. Some scientists have suggested that BSE may have been the result of cross species transmission from sheep as the result of feeding cattle animal proteins from dead sheep. By mid-2006 variant Creutzfeldt-Jakab disease had occurred in over 195 persons, and infected cattle had been identified in 24 additional countries.

Within a decade, food-borne infection by *Escherichia coli* 0157, unknown in the 1970s, had become a food-safety concern in Japan, Europe, and in the Americas. Hepatitis C was first identified in 1989 and is now thought to be present in at least 3% of the world's population, while hepatitis B has reached levels exceeding 90% in populations at high risk from the tropics to Eastern Europe.

In 2003, the severe acute respiratory syndrome (SARS) coronavirus was first identified, demonstrating the full potential of emerging infectious agents for international spread. Thought to be an animal virus from a yet unproven animal reservoir, the SARS coronavirus first infected humans in the Guangdong province of China in 2002. From China it rapidly spread to 26 countries, and resulted in over 8000 human cases during 2003.

In the Hong Kong Special Administrative Region of China, 18 cases of human zoonotic infection with influenza A virus subtype H5Nl occurred in 1997. Six of these cases were fatal. The H5N1 virus had been previously confined to wild bird populations, but around 1997 it began to infect domestic poultry in China and Hong Kong. By 1 December 2007, poultry infections were occurring throughout Asia, the Middle East, Europe, and Africa, and a total of 335 human zoonotic infections of H5N1 had occurred, of which 206 were fatal. The threat of emergence of a global influenza pandemic in humans continues, either as a result of adaptive mutation or reassortment of the H5N1 virus as it continues to circulate in nonhuman mammals and avian populations, or from one of the other avian influenza viruses now circulating in avian populations.

Human African trypanosomiasis, which had been virtually eliminated in the 1960s, resurged in an epidemic that in 1998 was thought to have infected 300 000 to 500 000 people. In 1976, the Ebola virus was first identified in simultaneous outbreaks of hemorrhagic fever in Democratic Republic of Congo and Sudan. In many ways, Ebola hemorrhagic fever has come to symbolize emerging diseases and their potential impact on human populations without previous immunological experience. The largest recorded outbreak, which began in Uganda in 2001, caused 425 confirmed cases and 224 deaths. Altogether, since 1976 Ebola has caused just under 2000 human infections of which approximately 1300 have been fatal, and epidemics continue to occur in west, central, and east African countries.

A retrospective analysis in 1985, of blood that had been collected from persons living in communities around the site of the 1976 Ebola outbreak, demonstrated that HIV seroprevalence was already almost 1%. HIV has since become a preoccupying problem in public health worldwide. Widespread infection with HIV, an infectious agent that is now endemic and appears to have emerged in human population sometime during the first half of the twentieth century, provides fertile ground for the transmission of tuberculosis, including extensively drug resistant-tuberculosis (XDR-TB), because HIV kills CD4 lymphocytes and destroys much of the acquired immune system. Drug-resistant tuberculosis has been identified in all regions of the world but is today most frequent in the countries of the former Soviet Union and in Asia, and is on the rise in Africa.

Misplaced Optimism {#s0015}
==================

With the certification of the eradication of smallpox in 1980, an unparalleled public health accomplishment that resulted in immeasurable prevention of human suffering and death, there was great optimism that infectious diseases were no longer a major threat. Vaccines and antimicrobial drugs that became available as the result of intensified research and development immediately following World War II provided further optimism, as well as technological advances in hygiene and sanitation.

Malaria, endemic in many industrialized countries in both North America and Europe, disappeared with the use of insecticides and antimalarial drugs. Tuberculosis hospitals in Europe and North America emptied as living conditions improved and effective drugs became available that could be used to treat those with acute tuberculosis and prevent infection in their contacts. Influenza deaths could be prevented in industrialized countries by vaccinating elderly populations, and epidemics of diarrhoeal disease became rare events, limited to foodborne outbreaks when temporary breaches in sanitation occurred.

This optimism resulted in a transfer of resources and infectious disease specialists away from infectious disease control and public health. More and more resources were invested in the development of drugs useful for noncommunicable diseases related to lifestyle and aging, and public health infrastructure weakened. At the same time, however, with increasing use of antimicrobial drugs, warning signs of microbial resilience began to appear and increase in magnitude.

At the end of the 1940s, resistance of hospital strains of *Staphylococcus* to penicillin in the United Kingdom had become as high as 14%. By the end of the 1990s it had risen to levels of 95% or greater, and by 2000 multidrug-resistant staphylococcal infections had become the cause of great public health concern. In New York City in the 1990s, multidrug-resistant strains of tuberculosis gained their hold in hospitals, prisons, and homeless populations. At the same time, multidrug-resistant tuberculosis emerged in the Russian Federation and the prevalence more than doubled in less than seven years, with over 20% of tuberculosis patients in prison settings infected with multidrug-resistant strains. Development of extensively drug-resistant tuberculosis rapidly followed, and by 2006 had become a major public health problem in southern Africa.

Levels of anti-infective drug resistance of *Staphylococcus aureus* and other microbes increased with great rapidity. By 1976, chloroquine-resistant *Plasmodium falciparum* malaria was highly prevalent in southeastern Asia and 20 years later was found worldwide, as was high-level resistance to two back-up drugs, sulfadoxine-pyrimethamine and mefloquine. Antimicrobial drugs developed to treat AIDS and other sexually transmitted infections such as gonorrhoea likewise began to lose their efficacy because of the rapid development of resistance. In the early 1970s, *Neisseria gonorrhoeae* that was resistant to usual doses of penicillin was just being introduced into Europe and the United States from Southeast Asia, where it is thought to have first emerged. By 1996, *N. gonorrhoeae* resistance to penicillin had become worldwide, and strains resistant to all major families of antibiotics had been identified wherever these antibiotics had been widely used. Countries in the Western Pacific, for example, have registered quinolone resistance levels up to 69%.

As a result of the shift in resources to other health priorities, vaccine and antimicrobial drug development lagged. No effective vaccines have been developed to prevent infection of many of the major mortality causing infections such as tuberculosis, malaria, and AIDS, and research and development of new antimicrobial agents has slowed.

Optimism is now being replaced by an understanding that the world is less well equipped to deal with infectious diseases because of emerging anti-infective drug resistance, and because the infrastructure for infectious disease surveillance and control has suffered and in some cases become ineffective. These weaknesses have recently come into sharp focus as countries consider preparedness plans for responding to the possible deliberate use of biological agents or a potential influenza pandemic, and recognize the importance of strong public health systems as the first line of defense for infectious disease outbreaks, irrespective of their origin.

Public Health Weakness Facilitating Emergence and Reemergence {#s0020}
=============================================================

The weakening of the public health infrastructure for infectious disease control is evidenced by the failures in mosquito control in Latin America and Asia that facilitated the reemergence of dengue that is now causing major epidemics. It was also evidenced in disinvestment in childhood immunization programes in Eastern Europe during the 1990s, which contributed to the reemergence of epidemic diphtheria; and in Africa and Latin America where yellow fever vaccination coverage markedly decreased, facilitating yellow fever outbreaks on both continents, the most severe of which was a major urban outbreak in Cote d'Ivoire in 2001.

Weakening of public health infrastructure is also clearly demonstrated by the high levels of hepatitis B and the nosocomial transmission of other pathogens such as HIV in the former Soviet Union and Romania, and the nosocomial amplification of outbreaks of Ebola in Democratic Republic of Congo, where syringes and failed barrier nursing amplified outbreaks into major epidemics.

Population increases and rapid urbanization have likewise resulted in the breakdown of sanitation and water systems in large coastal cities in Latin America, Asia, and Africa that promoted the transmission of cholera and shigellosis. In 1950, there were only two urban areas in the world with populations greater than 7 million, but by 2005 this number had risen to 34, with increasing populations in and around all major cities, challenging the capacity of existing water and sanitary systems.

Anthropogenic or natural effects on the environment also contribute to the emergence and reemergence of infectious diseases. The effects range from global warming and the consequent extension of vector-borne diseases, to ecological changes due to deforestation that increase contact between humans and animals and the possibility of microorganisms breaching the species barrier. These changes have occurred on almost every continent. They are exemplified by zoonotic diseases such as Lassa fever, first identified in West Africa in 1969 and now known to be transmitted to humans from human food supplies contaminated with the urine of rats that are in search of food, as their natural habitat could no longer support their needs.

In Latin America, Chagas disease emerged as an important human disease after mismanagement of deforested land caused triatomine populations to move from their wild natural hosts to involve human beings and domestic animals in the transmission cycle, eventually transforming the disease into an urban infection that can be transmitted by blood transfusion. Other zoonotic diseases that are increasing because of increased contact between people and naturally infected animal hosts include Lyme borreliosis in Europe and North America, transmitted to humans who come into contact with ticks that normally feed on rodents and deer, the reservoir of *Borrelia burgdorferi* in nature; and the Hantavirus pulmonary syndrome in Southwest North America.

The narrow band of desert in sub-Saharan Africa, in which epidemic *Neisseria meningitidis* infections traditionally occur, has enlarged as drought spread south, so that Uganda and Tanzania experience epidemic meningitis, while outbreaks of malaria and other vector-borne diseases have been linked to the cutting of the rainforests. In 1998 an outbreak of Japanese encephalitis in Papua New Guinea was linked to an extensive drought, which led to increased mosquito breeding as rivers dried into stagnant pools. The virus is now widespread in Papua New Guinea and other parts of Asia and threatening to move farther east. Buruli ulcer, a poorly understood mycobacterial disease that has emerged dramatically over the past decade, has erupted following significant environmental disturbances, and some evidence suggests that recent increases in Africa are linked to deforestation and subsequent flooding, or to the construction of dams and irrigation systems.

Finally, human behavior has played a role in the emergence and reemergence of infectious diseases, best exemplified by the increase in gonorrhea and syphilis during the late 1970s, and the emergence and amplification of HIV worldwide, which are directly linked to unsafe sexual practices and intravenous drug abuse. Human behavior has also facilitated the relentless evolution of anti-infective drug resistance. The mechanisms of resistance, a natural defense of microorganisms exposed to antimicrobial drugs, include both spontaneous mutation and genetic transfer. The selection and spread of resistant strains are facilitated by many factors, including human behavior in overprescribing drugs, in poor compliance, and in the unregulated sale of pharmaceuticals by nonhealth workers.

In Thailand, among 307 hospitalized patients, 36% who were treated with antiinfective drugs did not have an infectious disease. The overprescribing of antimicrobials occurs in most other countries as well. In Canada, it has been estimated that of the more than 26 million people treated with anti-infective drugs, 50% were treated inappropriately. Findings from community surveys of *E. coli* in the stool samples of healthy children in China, Venezuela, and the United States suggest that although multiresistant strains were present in each country, they were more widespread in Venezuela and China, countries where less control is maintained over antibiotic prescribing.

Animal husbandry and agriculture use large amounts of antimicrobials, and results in the selection of resistant bacterial strains in animals, which then genetically transfer the resistance factors to human pathogens or infect humans as zoonotic diseases, is a confounding factor that requires better understanding. Direct evidence exists that four multiresistant bacteria infecting humans, *Salmonella, Campylobacter, Enterococci*, and *E. coli*, are directly linked to resistant organisms in animals.

Globalization {#s0025}
=============

Infectious diseases emerge and reemerge in a world where international travel facilitates their spread. Though the role of travel in the spread of infectious diseases has been known for centuries, the speed of such travel has increased during the past 50 years. Today, a traveller can be in an European or Latin American capital one day and be in the center of Africa or Asia the next day. With them, humans often carry infectious agents, many times without knowledge of infection because it is still in its incubation period. Like insects, humans have become important vectors of diseases in a globalized world.

During the 1990s, over 500 million people traveled by air each year, and contributed to the growing risk of exporting or importing infection or drug-resistant organisms. In 1988, a clone of multiresistant *Streptococcus pneumoniae* first isolated in Spain was later identified in Iceland. Another clone of multiresistant *S. pneumoniae*, also first identified in Spain, was subsequently found in the United States, Mexico, Portugal, France, Croatia, Republic of Korea, and South Africa. A study conducted by the Ministry of Health of Thailand on 411 existing tourists showed that 11% had an acute infectious disease, mostly diarrheal, but also respiratory infections, malaria, hepatitis, and gonorrhea.

By 2006, international travel had increased to over 2 billion, and had greatly increased the ease with which microbes, incubating in unsuspecting humans, can cross continents and invade new geographic territories. Microbes living in insects concealed in cargoes or in the luggage holds and cabins of jets also take the same pathway. In the late 1990s West Nile fever arrived in North America through the introduction of a single virus subtype, and today has become endemic in avian populations throughout the United States and in Southern Canada and Northern Mexico.

Once established on new continents, emerging or reemerging infectious diseases can change population dynamics and negatively impact on economies. Nothing more clearly demonstrates this global threat than the spread of AIDS in humans throughout the world during the latter half of the twentieth century. AIDS has had a negative impact on economic development and healthy population growth. In recent years, every continent has experienced an unexpected outbreak of some infectious disease directly related to increased travel, one of the most recent having been SARS in 2003 which had a negative impact on travel and trade throughout Asia.

Parallel increases in trade have also facilitated the international spread of microbes, in animals traded internationally, or in improperly or nonprocessed food and food products. As a result, the threat of epidemic diseases with origins in one country and spread to others has become a real and constant threat. Trade is the reason that BSE in cattle has been found in 24 countries in which cattle and/or cattle products including animal feed were traded. Rift Valley fever is thought to have arrived in the Arabian peninsula in infected livestock traded across the Red Sea from Eastern Africa, and it has now become endemic in these new geographic areas, adding to the infectious disease burden.

Advances in food production and storage technology, coupled with the globalization of markets, have resulted in a food chain that is unprecedented in its length and complexity, thus creating an efficient vehicle for microbes to spread to new areas and susceptible hosts. Tracing the origin of all ingredients in a meal has become virtually impossible, constituting an enormous challenge for the control of foodborne diseases.

The universal nature of the microbial threat, with agents of disease, including drug-resistant forms, passing undetected across increasingly porous borders, has placed all nations on an equally vulnerable footing. Economic prosperity has produced a world that is interconnected in matters of economics and trade, with the result that health has become both a domestic issue, and an issue with foreign policy considerations as well ([Table 2](#t0010){ref-type="table"}). Table 2Resistance of common infectious diseases to antiinfective drugs, 1998DiseaseAntiinfective drugRange (%)Acute respiratory infection (*S. pneumoniae*)Penicillin12--55Diarrhea (*Shigella*)Ampicilline10--90TrimethoprimSulfamethoxazole9--95Gonorrhea (*N. gonorrhoeal*)Penicillin5--98MalariaChloroquine4--97TuberculosisRifampicin2--40IsonizidFluoroquinoloneAmikacinCapreomycinKanamycin[^2]

Solutions {#s0030}
=========

Attempts at regulation to prevent the spread of infectious diseases were first recorded in 1377 in quarantine legislation to protect the city of Venice from plague-carrying rats on ships from foreign ports. Similar legislation in Europe, and later the Americas and other regions, led to the first international sanitary conference in 1851, which laid down a principle for protection against the international spread of infectious diseases: maximum protection with minimum restriction. Uniform quarantine measures were determined at that time, but a full century elapsed, with multiple regional and interregional initiatives, before the International Sanitary Regulations were adopted in 1951. These were amended in 1969 to become the International Health Regulations (IHR), which are implemented by the World Health Organization (WHO).

The IHR (1969) provided a universal code of practice, which ranged from strong national disease detection systems and measures of prevention and control including vaccination, disinfection, and deratting. They initially required the reporting of four infectious diseases -- cholera, plague, smallpox, and yellow fever. But when these diseases were reported, the regulations were often misapplied, resulting in the disruption of international travel and trade, and huge economic losses. For example, when the cholera pandemic reached Peru in 1991, it was immediately reported to WHO. In addition to its enormous public health impact, however, misapplication of the regulations caused a severe loss in trade (due to concerns for food safety) and travel, which has been estimated as high as \$770 million. In 1994, an outbreak of plague occurred in India with approximately 1000 presumptive cases. The appearance of pneumonic plague resulted in thousands of Indians fleeing from the outbreak area, risking spread of the disease to new areas. Plague did not spread, but the outbreak led to tremendous economic disruption and concern worldwide, compounded by misinterpretation and misapplication of the IHR (1969).

A further problem with the regulations was that many infectious diseases, including those that are new or reemerging, were not covered even though they have great potential for international spread. These ranged from relatively infrequent diseases such as viral hemorrhagic fevers to the more common threat of meningococcal meningitis. Because of the problematic application and disease coverage of the IHR (1969), they have been revised and updated to make them more applicable to infection control and other public health menaces in the twenty-first century.

The revised IHR (2005) give a clear definition of what constitutes a public health emergency of international concern, thus helping countries to avoid inappropriate reactions to strictly localized events. They include unambiguous mechanisms for confidential collaboration between the affected country and WHO to verify the presence or absence of a suspected outbreak. For example, any event that may constitute a global public health threat is assessed by the country in which it is occurring using a decision instrument and, if certain criteria are met, an official notification must be provided to WHO. Notification is mandatory for a single case of human influenza caused by a new virus, poliomyelitis caused by a wild-type poliovirus, smallpox, and SARS. Potential threats are, however, no longer confined to a list of four communicable diseases. They include all public health emergencies of international concern, including those caused by other infectious agents, chemical agents, radioactive materials, and contaminated food.

To allow for a more sensitive and proactive system of detecting events and outbreaks, the IHR (2005) provide for a fundamental change in surveillance practices to include the use of unofficial information sources, such as the press or electronic media. The IHR (2005) are designed to become a true global alert and response system to ensure maximum protection against the international spread of diseases and other public health emergencies with minimum interference with trade and travel.

Finally, the IHR (2005) require the development of a core set of surveillance and control capacities in each country, and countries will be monitored by WHO to ensure that these capacities have been established. These capacities, along with efforts to minimize the impact of natural and anthropogenic changes in the environment, improved water and sanitation; effective communication of information about the prevention of infectious diseases; and more rationally prescribed use of antimicrobial drugs will help rebuild the weakened public health infrastructure. The challenge in the twenty-first century will be to continue to provide resources to strengthen and ensure more cost-effective infectious disease control, and implementation of the IHR (2005), while also providing the additional resources needed for other emerging public health problems such as those related to lifestyle and aging.

See also: {#mc0311}
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Glossary {#mc0312}
========

amplification of transmissionThe increased spread of infectious diseases that occurs naturally or because of facilitating factors, such as nonsterilized needles and syringes, that can result in an increase in transmission of infections such as hepatitis.anti-infective drug resistanceThe ability of a virus, bacterium, or parasite to defend itself against a drug that was previously effective. Drug resistance is occurring in bacterial infections such as 'tuberculosis' and 'gonorrhoea', in parasitic infections such as 'malaria', and in viral infections such as AIDS.emerging infectionA newly identified and previously unknown infectious disease in humans, often resulting from a breach in the species barrier between humans and animals that carry the infectious agent. Since 1970, there have been over 40 emerging infections identified, causing diseases ranging from diarrheal disease among children, hepatitis, and AIDS to Ebola and Marburg hemorrhagic fevers.eradicationThe complete interruption of transmission of an infectious disease and the disappearance of the virus, bacterium, or parasite that caused the infection. The only infectious disease that has been eradicated is 'smallpox', which was certified as eradicated in 1980.International Health Regulations (2005)International law that is intended to protect against the spread of infectious diseases across international borders, aimed at ensuring global public health security. The regulations provide new standards and norms for national and global disease surveillance, notification, and response; and require reporting to the World Health Organization (WHO) of all public health emergencies of international concern, including events or hazards arising from communicable diseases, biological, radionuclear, and chemical agents.reemerging infectionA known infectious disease that had fallen to such low prevalence or incidence that it was no longer considered a public health problem, but that is presently increasing in prevalence or incidence. Reemerging infections include 'tuberculosis', which has increased worldwide since the early 1980s, dengue in tropical regions, and 'diphtheria' in Eastern Europe.

[^1]: Reproduced from G. Rodier, WHO.

[^2]: Source: WHO.
